Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
The share price of Sunzen Biotech is forming a bullish descending triangle on the daily chart. This pattern is often a precursor to an upward breakout, signaling potential growth if the resistance level near RM0.32 is surpassed with strong volume. Key levels to watch:
Support: RM0.30
Resistance: RM0.32 (triangle upper trendline)
Sunzen has released its quarterly results, reporting a revenue of RM22.96 million and a PBT of RM0.86 million. During this quarter, 76.85% of the revenue came from human health products, 14.26% from loan financing, and the remaining 8.89% from the animal health segment.
Management expects better financial performance of the human health products business in the coming quarters considering the traditional peak season, with the increase in sales orders mainly to cater to the upcoming festive season
Ecolite Biotech is providing a two-year profit guarantee of RM10 million, while Yanming should contributing profit after tax of not less than RM3 million over the next two years.
Sunzen boleh meneroka penyelesaian kesihatan digital atau saluran runcit dlm talian utk mempromosikan produk TCM dan nutraseutikalnya. Memandangkan lebih ramai pengguna beralih kpd platform dlm talian utk maklumat dan produk kesihatan dan kesejahteraan, kehadiran digital yg kukuh boleh membantu Sunzen menjangkau khalayak yg lebih luas
